Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older.
- People with advanced breast cancer that has been confirmed through laboratory testing of tissue samples.
- People whose breast cancer falls into one of these categories: hormone receptor positive, HER2-positive or HER2-low, or triple negative breast cancer (TNBC) (confirm with trial site if unsure which category applies).
- Participation in the analysis requires that at least one full treatment cycle has already been completed.
Who may not be able to join:
- People diagnosed with early-stage breast cancer at the time of enrolling in the trial.
- People who are unwilling to sign a consent form agreeing to take part in the trial.
- People who are unwilling to provide a biological sample (such as blood or tissue) as part of the trial.
- People for whom complete and detailed medical records are not available.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elena Fountzilas, MD, PhD, Hellenic Cooperative Oncology Group
Phone: +302106912520
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS); Overall Survival (OS); Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.